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Dendritic cells are professional antigen-presenting cells that mediate immunity and tolerance.
Cheong et al. (2010) uncover a new route for dendritic cell production in vivo. They show that in
response to infection by gram-negative bacteria, monocytes are recruited to the lymph node where
they rapidly differentiate into dendritic cells that present antigens to T cells.Monocytes are circulating cells of the
mononuclear phagocyte system that have
been typically considered the precursors
of tissue macrophages. It therefore came
as a surprise that monocytes cultured
with the cytokines interleukin-4 (IL-4) and
granulocyte macrophage colony-stimu-
lating factor (GM-CSF) become dendritic
cells, the professional antigen-presenting
cells that initiate T cell responses in
lymphoid tissues (Sallusto and Lanzavec-
chia, 1994). These monocyte-derived
dendritic cells (Mo-DCs) capture soluble
antigens with high efficiency and respond
to microbial and inflammatory stimuli with
coordinated changes that enhance their
capacity for antigen presentation and
T cell stimulation. However, after more
than 15 years of study, the role of mono-
cytes and Mo-DCs in induction of T cell
responses in vivo remains unclear. In this
issue, Steinman and colleagues (Cheong
et al., 2010) show that in response to
injection of lipopolysaccharide (LPS) or
gram-negative bacteria, mouse mono-
cytes migrate to peripheral lymph nodes.
There they rapidly acquire the key proper-
ties of dendritic cells, such as a probing
morphology and the capacity to present
exogenous antigens to T cells that express
the cell surface markers CD4 (CD4+) and
CD8 (CD8+) (Cheong et al., 2010). These
data are compelling and the evidence
suggests that Mo-DCs have a prominent
role in initiating adaptive immunity to
gram-negative bacteria.
Two typesof residentdendriticcellswith
specialized functions are found in lymph
nodes and spleen (Figure 1): dendritic cells
that express CD8 and CD205 capture and
present cell-associated antigens to CD8+T cells in association withmajor histocom-
patibility complex (MHC) class I mole-
cules, a mechanism known as cross-
presentation, whereas dendritic cells that
express CD11b, but not CD8 or DEC-
205, capture and present soluble antigens
to CD4+ T cells in association with MHC
class II molecules. These two subsets
develop under the influence of Flt3-L
(Fms-like tyrosine kinase 3 ligand) from
pre-dendritic cells, circulating precursors
that have lost the capacity to differentiate
along the monocyte/macrophage lineage
(Liu and Nussenzweig, 2010). Several
studies using cell transfer experiments or
reporter mice provide definitive evidence
that in the steady state monocytes do not
contribute significantly to the dendritic
cell population of lymphoid organs (Jakub-
zick et al., 2008; Naik et al., 2006).
To detect Mo-DCs, Cheong et al. used
an antibody to mouse DC-SIGN, a lectin
receptor expressed on human Mo-DCs
generated in vitro but not on classical
dendritic cells (Geijtenbeek et al., 2000).
The authors show that mouse DC-SIGN/
CD209 is expressed at low levels on fresh
monocytes and upregulated upon culture
with GM-CSF and IL-4, concomitant with
loss of the monocyte markers Ly6C and
c-fms/CD115. Using this antibody to stain
tissue sections, the authors find very few
DC-SIGN-positive cells in lymph nodes
in the steady state. Strikingly, however,
in mice challenged with LPS, large
numbers of cells expressing DC-SIGN
rapidly appear in the paracortical T cell
areas of lymph nodes (Figure 1). Direct
evidence that DC-SIGN-positive dendritic
cells are derived from monocytes comes
from experiments with mice that expressCell 143the diphtheria toxin receptor in cells
of the monocyte/macrophage lineage.
When mice are treated with diphtheria
toxin, DC-SIGN-positive cells fail to accu-
mulate in lymph nodes following LPS
challenge.
Using an ingenious in vivo labeling
approach to isolate DC-SIGN-expressing
cells from lymph nodes, the authors show
that the newly recruited Mo-DCs effi-
ciently present and cross-present to
CD4+ and CD8+ T cells soluble and cell-
associated antigens that have been taken
up in vivo. These cells are even more
potent than the two resident subsets of
dendritic cells. Interestingly, Mo-DCs
occupy a slightly different niche in the
T cell area as compared to resident
dendritic cells, suggesting that T cells
may be differentially exposed to either
cell type. Further studies using intravital
microscopy combined with interventions
to selectively deplete particular subsets
of dendritic cells will be required to define
the relative contributions of Mo-DCs to
the induction of T cell proliferation and
differentiation in vivo.
The usefulness of antibodies to surface
markers in these studies cannot be over-
emphasized, given the extensive hetero-
geneity and functional specialization of
dendritic cells. In addition to DC-SIGN/
CD209, Cheong et al. show that two other
markers can be used to identify mouse
Mo-DCs in vivo: the mannose receptor
(MMR/CD206), which is also upregulated
in human Mo-DCs, and CD14, the LPS
coreceptor, which is expressed on human
and mouse monocytes. These reagents
provide useful tools for future studies on
the role of Mo-DCs in immune response., October 29, 2010 ª2010 Elsevier Inc. 339
Figure 1. Dendritic Cell Differentiation and Antigen Presentation in the Lymph Node
Lymph node-resident dendritic cells comprise DEC-205+ and DEC-205 cells that are the progeny of
a circulating pre-dendritic cell precursor. The two types of resident dendritic cells are specialized for
presentation of antigen toCD8+ andCD4+ T cells, respectively. Upon systemic challenge with lipopolysac-
charide (LPS) or gram-negative bacteria, blood monocytes enter the lymph node through the high endo-
thelial venules and rapidly differentiate to dendritic cells that efficiently present antigen to CD4+ and CD8+
T cells. These cells can be identified according to the expression of DC-SIGN, MMR (macrophage
mannose receptor), and CD14. Monocyte-derived dendritic cells can also migrate to the lymph node
from infected or inflamed tissues through the afferent lymph.How do monocytes and Mo-DCs reach
lymph nodes? The conventional view is
that monocytes first enter infected or in-
flamed nonlymphoid tissues where they
capture antigen,mature, andsubsequently
migrate to the draining lymph nodes via the
afferent lymph (Leon et al., 2007; Randolph
et al., 1999). In contrast, Cheong et al.
report that monocytes migrate into lymph
nodes in a manner dependent on the cell
adhesionmoleculeCD62L and the chemo-
kine receptor CCR7, consistent with
a direct migration from blood through the
high endothelial venules (Figure 1). The
implication from these new findings is that
depending on the nature of the microbe
and its route of entry, monocytes can pref-
erentially use one or the other pathway of
migration and differentiation.
An intriguing finding of the study by
Cheong et al. is that monocyte migration
to lymph nodes and differentiation to
antigen-presenting Mo-DCs could be eli-
cited by administration of LPS or gram-
negative bacteria, but not by administra-
tion of other Toll-like receptor (TLR)340 Cell 143, October 29, 2010 ª2010 Elseviagonists or gram-positive bacteria. A
possible explanation may lie in a marked
upregulation of TLR4 and CD14 onmouse
Mo-DCs, but it is worth asking whether
this phenomenon is indeed limited to
systemic challenge with gram-negative
bacteria. Another intriguing finding is
that Mo-DCs are found only in peripheral
lymph nodes but not in spleen or mesen-
teric lymph nodes. Other studies have
shown that monocytes can be recruited
to the spleen by macrophages infected
with Listeria monoytogenes (Serbina
et al., 2003). There the monocytes
develop into inflammatory dendritic cells
that mediate protection from infection
through production of tumor necrosis
factor (TNF) and inducible nitric oxide syn-
thase (iNOS) but do not contribute to
induction of T cell responses. It is possible
that different gradients of chemokines
and cytokines elicited in different tissues
by microbial infection may determine the
recruitment of monocytes and their differ-
entiation into either inflammatory effector
cells or antigen-presenting dendritic cells.er Inc.It will be interesting to determine
whether and which cytokines trigger the
rapid differentiation of dendritic cells
from monocytes in the system used by
Cheong et al. GM-CSF is capable of
driving Mo-DC differentiation in vitro and
together with M-CSF and Flt3-L has been
shown to regulate the differentiation of
monocytes, macrophages, and dendritic
cells from bone marrow progenitors
in vivo (Schmid et al., 2010). A better
understanding of the role of GM-CSF and
other cytokines in the generation of Mo-
DCs may provide new insights into their
use as adjuvants for vaccination.
Dendritic cells are highly heterogeneous
with respect to their capacity to respond to
microbial and danger stimuli, to process
and present self and non-self antigens,
and to produce cytokines and costimula-
tory molecules that lead to different
immune responses, from Th1-, Th2-, and
Th17-mediated effector responses to
suppression and tolerance. The new study
by Cheong et al. provides conclusive
evidence that monocytes belong to the
extended dendritic cell family and intro-
duces useful tools to study the role of
Mo-DCs in thesedifferent typesof immune
responses.
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